Resection for pancreatic cancer metastases contributes to survival-Reference-Cited by-同舟云学术

Resection for pancreatic cancer metastases contributes to survival

Published:2020-06-19 Issue:25 Volume:99 Page:e20564
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Sato Hiroki,Sasajima Junpei,Okada Tetsuhiro,Hayashi Akihiro,Kawabata Hidemasa,Goto Takuma,Koizumi Kazuya,Tamamura Nobue,Tanabe Hiroki,Fujiya Mikihiro,Chiba Shin-ichi,Tanino Mishie,Ono Yusuke,Mizukami Yusuke,Okumura Toshikatsu

Funder

Japan Society for the Promotion of Science KAKENHI

the Japan Society for the Promotion of Science KAKENHI

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference30 articles.

1. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013

2. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01);Uesaka;Lancet,2016

3. Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival;Arnaoutakis;J Gastrointest Surg,2011

4. Adenocarcinoma of the pancreas: does prognosis depend on mode of lymph node invasion?;Buc;Eur J Surg Oncol,2014

5. Diversity of precursor lesions for pancreatic cancer: the genetics and biology of intraductal papillary mucinous neoplasm;Patra;Clin Transl Gastroenterol,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic Pancreatic Cancer Now in Remission: A Case Report and Literature Review;2024-08-01